Pace® expert to leverage extensive knowledge to provide guidance on risk assessments for pharmaceutical and biopharmaceutical companies MINNEAPOLIS, MN –
Company commitment to quality excellence confirmed during FDA Inspection MINNEAPOLIS, MN – August 21, 2025– Pace® Life Sciences, a U.S.-based contract,
The United States is global powerhouse in pharmaceutical contract development and manufacturing, home to some of the world’s most advanced
Company reopens state-of-the-art isolated vial filling line at Aseptic Fill-Finish Center of Excellence MINNEAPOLIS, MN – August 12, 2025 –
Research Triangle Park, NC site received a positive FDA Review, marking a milestone as all company Analytical Outsourcing sites have
July 16 open house highlights expanded sterile filling contract manufacturing capabilities for small and large molecules Minneapolis, MN – July
Company confirms high standards for data integrity and quality systems MINNEAPOLIS, MN, May 20, 2025 Pace® Life Sciences, a U.S.-based full-service
With a growing network of locations across major US pharmaceutical hubs, Pace® aims to enhance customer experience through consistent quality
Company stands out in Ethics, Environment, and Labor and Human Rights focus areas for 2024 Minneapolis, MN – April 1,
The modern therapeutic landscape is defined by an ever-growing portfolio of complex drug products – from biologics and gene therapies
